Cytokeratin 20 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cytokeratin 20 monoclonal antibodies for research in cell biology and pathology. Cytokeratin 20 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytokeratin 20 is a type of intermediate filament protein primarily expressed in epithelial cells, particularly in the gastrointestinal tract and bladder. Its presence is crucial for maintaining the structural integrity of epithelial tissues and plays a significant role in cellular processes such as differentiation and apoptosis. Additionally, Cytokeratin 20 serves as a biomarker in cancer diagnostics, particularly in identifying metastatic tumors. Understanding Cytokeratin 20 expression patterns helps researchers track changes in epithelial cell development and disease progression. Monitoring Cytokeratin 20 levels provides valuable insights into tissue-specific gene expression and cellular differentiation states. Studying Cytokeratin 20 distribution patterns aids in understanding epithelial tissue organization and maintenance. Santa Cruz Biotechnology monoclonal antibodies targeting Cytokeratin 20 enable researchers worldwide to advance our understanding of epithelial cell biology and cancer research.